Lite Strategy (LITS) Return on Capital Employed [ROCE] (2011 - 2026)
Lite Strategy (LITS) recorded Return on Capital Employed [ROCE] of -135.40% in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 39.37 percentage points from -96.02% a year earlier and down 51.70 percentage points from the prior quarter.
Powered by 
Analysis
Lite Strategy (LITS) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Lite Strategy reported Return on Capital Employed [ROCE] of -226.30%, down 165.01 percentage points from FY2025.
- Annual Return on Capital Employed [ROCE] has a five-year change of -191.11 percentage points (FY2021 to FY2026).
- Across earlier fiscal years, Return on Capital Employed [ROCE] came in at -61.30% in FY2025 (-81.29 pp), 19.99% in FY2024 (+48.50 pp), -28.50% in FY2023 (+21.31 pp) and -49.82% in FY2022 (-14.62 pp).
- The fiscal Q4 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] since fiscal Q3 2025.
- On a year-over-year basis, Return on Capital Employed [ROCE] rose in three of the last eight quarters, with an average year-over-year change of -49.92 percentage points.
- Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 135.07 percentage points in fiscal Q1 2026, against a drop of 191.60 percentage points in fiscal Q3 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at -83.70% (Q3 2026), -40.45% (Q2 2026) and -19.84% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.86% |
| 10 | Lite Strategy | 37.59 Mn | 5.47 Mn | - | -135.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -135.40% |
| Mar 31, 2026 | -83.70% |
| Dec 31, 2025 | -40.45% |
| Sep 30, 2025 | -19.84% |
| Jun 30, 2025 | -96.02% |
| Mar 31, 2025 | -157.22% |
| Dec 31, 2024 | -170.78% |
| Sep 30, 2024 | -154.91% |
| Jun 30, 2024 | 30.32% |
| Mar 31, 2024 | 34.38% |
| Dec 31, 2023 | 19.40% |
| Sep 30, 2023 | 35.85% |
| Jun 30, 2023 | -34.31% |
| Mar 31, 2023 | -35.71% |
| Dec 31, 2022 | -35.39% |
| Sep 30, 2022 | -49.97% |
| Jun 30, 2022 | -46.68% |
| Mar 31, 2022 | -42.00% |
| Dec 31, 2021 | -40.88% |
| Sep 30, 2021 | -43.88% |
API Access
Lite Strategy Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LITS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "LITS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LITS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();